U.S. cannabis firm PharmaCann plans IPO as
PharmaCann, one of the 10 original cannabis licensees in New York, has confidentially filed
Please be informed that a specific anonymous source is attempting a cyber-attack to damage the reputation of World Economic Magazine. They might attempt to access your personal or professional email under the guise of making untrue accusations against our company via email, the internet, etc. You are urged to use extreme caution when receiving such emails because these statements are false and fraudulent.
Please note that we never owed any monetary dues to any party whatsoever. Any agency or source claiming otherwise, is doing so solely with a deceitful intention and is a part of fraudulent activities
PharmaCann, one of the 10 original cannabis licensees in New York, has confidentially filed
Shares of Pfizer Inc (PFE.N) hit a record high on Tuesday for the first time in
Deutsche Bank AG (DBKGn.DE) has hired two new managing directors for its healthcare investment banking team
BioNTech and partner Pfizer (PFE.N) have supplied more than one billion doses of their COVID-19 vaccine
Merck KGaA (MRCG.DE) raised its outlook after posting forecast-beating second quarter profits on Thursday,
CVS Health Corp (CVS.N) on Wednesday hedged a bit on its long-term target for
PARIS, Aug 3 (Reuters) – French drugmaker Sanofi (SASY.PA) said it had made a $3.2 billion
Second-quarter sales of AstraZeneca's (AZN.L) COVID-19 vaccine more than tripled to $894 million from
The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion
TUNIS, July 16 (Reuters) – Italy, Spain and Switzerland sent medical aid on Friday